SureTrader Nadex Advertisement Interactive Brokers Advertisement SureTrader
Home > Boards > US Listed > Medical - Drugs >

Novartis (NVS)

NVS RSS Feed
Add NVS Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 5/19/2017 10:08:45 AM - Followers: 16 - Board type: Free - Posts Today: 0
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NVS
Current Price
Volume:
Bid Ask Day's Range
NVS News: DURECT and Sandoz have Signed a $293 Million Development and Commercialization Agreement for POSIMIR® (SABER®-Bupivacaine) ... 05/08/2017 07:00:00 AM
NVS News: Propeller Health Enters into Collaboration to Connect Breezhaler™ Devices to the Propeller Platform 02/08/2017 06:00:00 AM
PostSubject
#306  Sticky Note NVS could take $15-25B loss on Alcon sale: DewDiligence 04/21/17 11:23:13 AM
#309   CHMP approves Zykadia in first-line ALK+ NSCLC: DewDiligence 05/19/17 10:08:45 AM
#308   https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm555778.htm?source= mikekrane 04/28/17 12:17:29 PM
#307   NVS 1Q17 CC slides: DewDiligence 04/25/17 07:09:11 PM
#306   NVS could take $15-25B loss on Alcon sale: DewDiligence 04/21/17 11:23:13 AM
#305   NVS, AGN collaborate on phase-2b for NASH combo: #msg-130568056. DewDiligence 04/18/17 11:00:25 AM
#304   NVS licenses dry-eye drug candidate from (private) Lubris, DewDiligence 04/07/17 11:24:09 AM
#303   Serelaxin fails revamped phase-3 trial in acute HF: #msg-129752197. DewDiligence 03/22/17 09:44:43 AM
#302   FDA approves NVS’ Kisqali (f/k/a LEE011) for first-line DewDiligence 03/13/17 05:57:43 PM
#301   Novartis AG (ADR) (NYSE:NVS) Fined And Some Products trendmkr 03/03/17 12:56:01 PM
#300   Novartis AG (NYSE:NVS) Greater Use Of Technology In trendmkr 02/14/17 12:13:58 PM
#298   Some info about NVS’ RTH258 for AMD: #msg-128240149. DewDiligence 01/29/17 06:53:41 PM
#297   NVS CC slides… DewDiligence 01/25/17 07:04:17 AM
#296   NVS inks two deals… DewDiligence 12/20/16 09:43:21 AM
#295   Down nearly 4% in one day on good Ecomike 10/25/16 07:40:53 PM
#294   NVS 3Q16 CC slides: DewDiligence 10/25/16 10:25:03 AM
#293   NVS’ LEE011 data impress in first-line HR+/HER2- breast DewDiligence 10/08/16 04:45:07 PM
#292   NVS presents phase-3 data in SPMS: DewDiligence 09/18/16 03:56:47 PM
#291   NVS reduces MNTA stake via 10b5-1 plan: #msg-124870976. DewDiligence 08/30/16 05:57:38 PM
#290   What will NVS do about AMGN's Enbrel patent DewDiligence 08/30/16 05:56:51 PM
#289   FDA approves NVS’ Enbrel FoB, but... #msg-124870707. DewDiligence 08/30/16 05:35:31 PM
#288   NVS hits phase-3 primary endpoint in SPMS: DewDiligence 08/25/16 10:21:36 AM
#287   Novartis AG Licenses LGT209 To Cyon Therapeutics, Teams venturecapp 08/24/16 12:22:56 PM
#286   NVS’ recent-launch successes—Cosentyx yes, Entresto no: DewDiligence 07/19/16 11:24:57 AM
#285   FDA rejects NVS' Enbrel FoB: #msg-123963130. DewDiligence 07/19/16 10:31:47 AM
#284   NVS 2Q16 CC slides: DewDiligence 07/19/16 10:30:23 AM
#283   will be 90 by next year Fibanotch 06/10/16 05:11:59 PM
#282   Novartis, Eisai To Cooperate In Cancer Drugs Marketing venturecapp 06/08/16 10:50:38 AM
#281   NVS to run 40+ Entresto trials to boost sales: DewDiligence 05/19/16 04:10:33 PM
#280   $NVS recent news/filings stocktrademan 03/18/16 04:33:30 PM
#279   Entresto is off to a slow start: #msg-121250538. DewDiligence 03/16/16 06:20:43 PM
#278   Looks like Offices are being Raided over Bribery PENNYMACHINE 02/22/16 12:22:29 PM
#277   The 20-F annual report has been filed: DewDiligence 01/27/16 08:34:50 AM
#276   NVS 4Q15 CC slides: DewDiligence 01/27/16 07:08:54 AM
#275   Alcon has become a serious drag on NVS: #msg-119762239. DewDiligence 01/11/16 07:42:12 PM
#274   Entresto might increase risk of AMD and AD, DewDiligence 12/10/15 03:25:56 PM
#273   Novartis Reaffirms its CAR T Dominance venturecapp 12/07/15 12:29:48 PM
#272   FDA approves generic Gleevec from Sun Pharma: #msg-118939751. DewDiligence 12/04/15 12:50:56 PM
#271   FDA reviewing NVS’ 351(k) submission for Neulasta FoB: #msg-118583523. DewDiligence 11/18/15 10:18:57 AM
#270   AVEO 8-K filing today: Novartis AV-380 Inventory Reimbursement ProfitScout 11/16/15 07:33:49 PM
#269   NVS 10 MINUTES TREND1 11/12/15 09:44:37 PM
#268   NVS D TREND1 11/07/15 07:36:22 PM
#267   3Q15 results were in-line with prior guidance DewDiligence 11/06/15 09:28:03 AM
#266   Was it good or bad? Ecomike 11/06/15 01:13:00 AM
#265   MEMS Journal ranks $NVS as a Major Player vikingzskillz 11/05/15 05:33:30 PM
#264   50 BELOW 200 EMA LONG TERM DOWN TREND1 11/03/15 12:33:45 PM
#263   EPS = $44.21 TREND1 11/03/15 12:32:00 PM
#262   NVS DAY 1.4 YEARS TREND1 11/03/15 12:31:12 PM
#261   Novartis' inhaler for COPD gets FDA approval TREND1 11/03/15 12:25:40 PM
#260   NVS 3Q15 results… DewDiligence 10/27/15 09:35:08 AM
#259   NVS launches Zarxio (Neupogen FoB) at ~15% price DewDiligence 09/03/15 10:35:05 AM
PostSubject